Vasoactive intestinal peptide antagonist (Emory University)

N/A

Report date: 2025/01/26 17:40:00
NME

Base Information

Drug NameVasoactive intestinal peptide antagonist (Emory University)
Drug Alias NameVIPhybvasoactive intestinal peptide antagonist (Emory University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasoactive intestinal peptide receptor antagonists
TargetsVasoactive intestinal peptide receptor
Therapy Area/IndicationsGraft vs Host DiseaseColonic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesEmory University
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseColonic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A